Non-invasive skin imaging to measure circulation in people with diabetes or heart risk
Tests a non-invasive skin imaging device in adults with diabetes or cardiovascular risk.
Plain-language title generated from the registry record
Registry title: Non-invasive Imaging for In-vivo Quantification of Skin Composition and Structure
Key facts
- Where
- Stockholm, SwedenSee the 3 sites
Where in Sweden
- Atrium Health Care CentreStockholm, SwedenTaking people
- Neko Health Centre, RegeringsgatanStockholm, SwedenTaking people
- Neko Health Centre, SibyllegatanStockholm, SwedenTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- HJN Sverige AB/Neko Health
- Trial code
- NCT06976073
- Record updated
- 16 May 2025
- Original description
The goal of this clinical investigation is to explore a non-invasive technology for measuring the microcirculatory structure, composition and function in patients from a primary care population.Read full original descriptionShow less
Non-invasive Imaging for In-vivo Quantification of Skin Composition and Structure
The goal of this clinical investigation is to explore a non-invasive technology for measuring the microcirculatory structure, composition and function in patients from a primary care population.
The main aims are:
1. To evaluate the robustness of the technology for assessment of the molecular composition and structure of the skin tissue and microcirculatory function, on a prospective primary care population. 2. To evaluate the device and method on its capability to detect deficiencies in circulation, compared with existing reference systems with similar characteristics for patients with known cardiovascular disease risk and/or diabetes.
Inclusion: Adult patients part of the regular healthcare patient flow at the investigational sites, or as separately invited to participate in this investigation; Patients with signed informed consent.
Exclusion: Cognitive impairment; Other severe disorder or terminal disease; Patients unable to understand the oral and written study information in Swedish or English; Patients unable to provide an informed consent; Patient´s with damaged, scarred or non-intact skin within the skin area of interest.